Urology Fellowship Publications, 2010 - February 2012

Guru KA. Editorial Comment. J Urol. 2011 Sep;186(3):1024.

Challacombe BJ, Bochner BH, Dasgupta P, Gill I, Guru K, Herr H, Mottrie A, Pruthi R, Redorta JP, Wiklund P. The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications. Eur Urol. 2011 Oct;60(4):767-75.

Guru K, Menon M. How do we improve techniques in robotic surgery? J Urol. 2011 Apr;185(4):1186-7.

Rehman J, Sangalli MN, Guru K, de Naeyer G, Schatteman P, Carpentier P, Mottrie A. Total intracorporeal robot-assisted laparoscopic ileal conduit (Bricker) urinary diversion: technique and outcomes. Can J Urol. 2011 Feb;18(1):5548-56.

Erwin DP, Erwin DO, Ciupak G, Hellenthal N, Sofi MJ, Guru KA, Edge SB. Challenges and implementation of a women's breast health initiative in rural Kashmir. Breast. 2011 Apr;20 Suppl 2:S46-50.

Hayn MH, Hellenthal NJ, Seixas-Mikelus SA, Mansour AM, Stegemann A, Hussain A, Guru KA. Is patient outcome compromised during the initial experience with robot-assisted radical cystectomy? Results of 164 consecutive cases. BJU Int. 2011 Sep;108(6):882-7.

Hayn MH, Hellenthal NJ, Hussain A, Stegemann AP, Guru KA. Defining morbidity of robot-assisted radical cystectomy using a standardized reporting methodology. Eur Urol. 2011 Feb;59(2):213-8.

Seixas-Mikelus SA, Stegemann AP, Kesavadas T, Srimathveeravalli G, Sathyaseelan G, Chandrasekhar R, Wilding GE, Peabody JO, Guru KA. Content validation of a novel robotic surgical simulator. BJU Int. 2011 Apr;107(7):1130-5.

Hayn MH, Guru KA, Kim HL. Simplified laparoscopic partial nephrectomy using a single-layer closure and no bolsters for renal tumors. Urology. 2011 Feb;77(2):344-9.

Hellenthal NJ, Hussain A, Andrews PE, Carpentier P, Castle E, Dasgupta P, Kaouk J, Khan S, Kibel A, Kim H, Manoharan M, Menon M, Mottrie A, Ornstein D, Palou J, Peabody J, Pruthi R, Richstone L, Schanne F, Stricker H, Thomas R, Wiklund P, Wilding G, Guru KA. Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. BJU Int. 2011 Feb;107(4):642-6.

Song L, Mishel M, Bensen JT, Chen RC, Knafl GJ, Blackard B, Farnan L, Fontham E, Su LJ, Brennan CS, Mohler JL, Godley PA. How does health literacy affect quality of life among men with newly diagnosed clinically localized prostate cancer?: Findings from the North Carolina-Louisiana Prostate Cancer Project (PCaP). Cancer. 2011 Dec 16.

Moran BJ, DeRose P, Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Rosenthal SA, Rossi CJ Jr, Yamada Y, Merrick GS. ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer. Am J Clin Oncol. 2011 Dec;34(6):636-47.

Ciezki JP, Hsu IC, Abdel-Wahab M, Arterbery VE, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G. American College of Radiology Appropriateness Criteria(®) - Locally Advanced (High-risk) Prostate Cancer. Clin Oncol (R Coll Radiol). 2012 Feb;24(1):43-51.

Mohler JL, Titus MA, Wilson EM. Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone. Clin Cancer Res. 2011 Sep 15;17(18):5844-9.

Godoy A, Kawinski E, Li Y, Oka D, Alexiev B, Azzouni F, Titus MA, Mohler JL. 5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression. Prostate. 2011 Jul;71(10):1033-46.

Expert Panel on Radiation Oncology-Prostate, Frank SJ, Arterbery VE, Hsu IC, Abdel-Wahab M, Ciezki JP, Hahn NM, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G. American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer. Brachytherapy. 2011 Sep-Oct;10(5):357-62.

Su LJ, Arab L, Steck SE, Fontham ET, Schroeder JC, Bensen JT, Mohler JL. Obesity and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study. Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):844-53.

Xu Z, Bensen JT, Smith GJ, Mohler JL, Taylor JA. GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP). Prostate. 2011 Jun 1;71(8):881-91. doi: 10.1002/pros.21304.

Hayn MH, Orom H, Shavers VL, Sanda MG, Glasgow M, Mohler JL, Underwood W 3rd. Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer. Cancer. 2011 Mar 31.

Mohler JL, Titus MA, Bai S, Kennerley BJ, Lih FB, Tomer KB, Wilson EM. Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer. Cancer Res. 2011 Feb 15;71(4):1486-96.

Mohler JL, Pantuck AJ. Use of abiraterone for prostate cancer. J Urol. 2011 Mar;185(3):783-6.

Godoy A, Montecinos VP, Gray DR, Sotomayor P, Yau JM, Vethanayagam RR, Singh S, Mohler JL, Smith GJ. Androgen deprivation induces rapid involution and recovery of human prostate vasculature. Am J Physiol Endocrinol Metab. 2011 Feb;300(2):E263-75.

Kapoor DA, Zimberg SH, Ohrin LM, Underwood W 3rd, Olsson CA. Utilization trends in prostate cancer therapy. J Urol. 2011 Sep;186(3):860-4.

Su C, Underwood W, Rybalchenko N, Singh M. ERK1/2 and ERK5 have distinct roles in the regulation of brain-derived neurotrophic factor expression. J Neurosci Res. 2011 Oct;89(10):1542-50.

Underwood W, Kim HL. Intermediate-term oncological efficacy of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ cell testicular cancer. BJU Int. 2012 Jan;109(2):281-5.

Ross L, Dark T, Orom H, Underwood W 3rd, Anderson-Lewis C, Johnson J, Erwin DO. Patterns of information behavior and prostate cancer knowledge among African-American men. J Cancer Educ. 2011 Dec;26(4):708-16.

Hayn MH, Schwaab T, Underwood W, Kim HL. RENAL nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomy. BJU Int. 2011 Sep;108(6):876-81.

Ademuyiwa FO, Edge SB, Erwin DO, Orom H, Ambrosone CB, Underwood W 3rd. Breast cancer racial disparities: unanswered questions. Cancer Res. 2011 Feb 1;71(3):640-4.

Brewer K, O’Malley RL, Hayn M, Safwat MW, Kim H, Underwood III W, Schwaab T. Peri-operative And Renal Function Outcomes Of Minimally Invasive Partial Nephrectomy For T1b and T2a Kidney Tumors. J Endourol. 2011 Dec 22.

Schwaab T, Ernstoff MS. Therapeutic vaccines in renal cell carcinoma. Therapy. 2011 Jul;4(8):369-377.

Schwaab T, Pili R. Provenge: combating prostate cancer with a vengeance? Expert Rev Vaccines. 2011 Aug;10(8):1113-4.

Hellenthal NJ, Mansour AM, Hayn MH, Schwaab T. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma? Urol Oncol. 2011 Mar 9.

Hellenthal NJ, Mansour AM, Hayn MH, Schwaab T. Renal cell carcinoma in octogenarians: nephron sparing surgery should remain the standard of care. J Urol. 2011 Feb;185(2):415-20.

Chadha KC, Nair BB, Chakravarthi S, Zhou R, Godoy A, Mohler JL, Aalinkeel R, Schwartz SA, Smith GJ: Enzymatic activity of free-prostate-specific antigen (f-PSA) is not required for some of its physiological activities. The Prostate 2011, 71(15):1680-1690.

Azzouni, F., & Mohler, J. (2012). Role of 5alpha-reductase inhibitors in benign prostatic diseases. Prostate Cancer Prostatic Dis. doi: 10.1038/pcan.2012.1

Azzouni, F., Godoy, A., Li, Y., & Mohler, J. (2012). The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases. Adv Urol, 2012, 530121. doi: 10.1155/2012/530121

Godoy A, Kawinski E, Li Y, Oka D, Alexiev B, Azzouni F, Titus MA, Mohler JL: (2010). 5alpha-reductase type 3 expression in human benign and malignant tissues: A comparative analysis during prostate cancer progression. Prostate. doi: 10.1002/pros.21318

Godoy A, Kawinski E, Li Y, Oka D, Alexiev B, Azzouni F, Titus MA, Mohler JL: 5alpha-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression. The Prostate 2011, 71(10):1033-1046.

Heemers HV, Schmidt LJ, Sun Z, Regan KM, Anderson SK, Duncan K, Wang D, Liu S, Ballman KV, Tindall DJ: "Identification of a clinically relevant androgen-dependent gene signature in prostate cancer." Cancer Res 71(5): 1978-88.

Kowalik, T. and T. Schwaab "Editorial comment for San Francisco et al." J Endourol 25(2): 308-9.

O'Malley RL, Brewer KA, Hayn MH, Kim HL, Underwood W, 3rd, Pili R, Schwaab T: "Impact of cytoreductive nephrectomy on eligibility for systemic treatment and effects on survival: are surgical complications or disease related factors responsible?" Urology 78(3): 595-600.

Schwaab, T. and M. S. Ernstoff "Therapeutic vaccines in renal cell carcinoma." Therapy 4(8): 369-377.

Efstathiou E, Titus M, Tsavachidou D, Tzelepi V, Wen S, Hoang A, Molina A, Chieffo N, Smith LA, Karlou M "Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone." J Clin Oncol.

Titus, M. and K. B. Tomer "Androgen quantitation in prostate cancer tissue using liquid chromatography tandem mass spectrometry." Methods Mol Biol 776: 47-57.

Hayn MH, Hellenthal NJ, Hussain A, Andrews PE, Carpentier P, Castle E, Dasgupta P, Davis R, Thomas R, Khan S (2010). "Does previous robot-assisted radical prostatectomy experience affect outcomes at robot-assisted radical cystectomy? Results from the International Robotic Cystectomy Consortium." Urology 76(5): 1111-1116.

Hayn, M. H., A. Hussain, et al. (2010). "The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium." Eur Urol 58(2): 197-202.

Hayn MH, Hussain A, Mansour AM, Andrews PE, Carpentier P, Castle E, Dasgupta P, Rimington P, Thomas R, Khan S. (2010). "Reply from authors re: Urs E. Studer, Laurence Collette. Robot-assisted cystectomy: does it meet expectations? Eur Urol 2010;58:203-4." Eur Urol 58(2): 204-206.

Guru K, Seixas-Mikelus SA, Hussain A, Blumenfeld AJ, Nyquist J, Chandrasekhar R, Wilding GE: (2010). "Robot-assisted intracorporeal ileal conduit: Marionette technique and initial experience at Roswell Park Cancer Institute." Urology 76(4): 866-871.

Seixas-Mikelus SA, Mehedint DC, Chandrasekhar R, Wilding GE, Mohler JL. Open versus robotic super-radical prostatectomy. Urol Oncol (Submitted: April 2011).

Poch M, Underwood W, Moore DT, Maygarden SJ, Schell MJ, Mohler JL. Progression of prostate cancer in African and Caucasian Americans who choose observation (In Preparation).

Kesavadas T, Stegemann A, Sathyaseelan G, Chowriappa A, Srimathveeravalli G, Seixas-Mikelus S, Chandrasekhar R, Wilding G, Guru K. Validation of Robotic Surgery Simulator (RoSS), Stud Health Technol Inform. 2011 163: 274-276

Poch MA, Stegemann AP, Sharif MA, Hayn MH, Hussain A, Consiglio JD, Wilding GE, Guru KA. Short-term Patient Reported HRQOL Status After Robot-Assisted Radical Cystectomy Using the Bladder Cancer Index and Body Image Scale (In Preparation).

Hayn MH, El-Nahas A, Stegemann AP,  Agarwal PK, Badani KK, Balbay MD, Castle EP, Dasgupta P, Ghavamian R, Hemal AK, Hollenbeck BK, Josephson D, Kader AK, Kahn S, Kibel AS, Menon M, Mottrie A, Nepple K, Pattaras JG, Peabody JO, Poulakis V, Pruthi RS, Redorta JP, Rha KH, Richstone L, Saar M, Scherr DS, Siemer S, Stoeckle M, Wallen EM, Weizer AZ, Wiklund P, Wilson T, Guru KA. Is Robot-Assisted Radical Cystectomy Effective for T3 Bladder Cancer? Results from the International Robotic Cystectomy Consortium (In Preparation).

Poch MA, Stegemann A, Chandrasekhar R, Hayn M, Wilding G, Guru KAD: Does Body Mass Index Impact the Performance of Robot-Assisted Intracorporeal Ileal Conduit? Journal of endourology / Endourological Society 2012.